Resources>Citations Database>Novel PAP-targeted CAR-T therapy enhances antitumor efficacy through CoupledCAR approach

Novel PAP-targeted CAR-T therapy enhances antitumor efficacy through CoupledCAR approach

Biointron 2025-05-31

Authors: Zhiyuan Cao, Chengfei Pu, Xianyang Jiang, Guiting Han, Xiaogang Shen, Wensheng Wang, Wei Ding, Zhipeng Huang, Xi Huang, Beibei Jia, Victor X Lu, Le Tian, Zhao Wu, Lei Xiao

Journal: Journal for ImmunoTherapy of Cancer

PubMed ID: 40449956

DOIhttps://doi.org/10.1136/jitc-2024-011238

Products & Services: PAP antibody (BioIntron, B21482901) was used to measure PAP expression on the surfaces of PC3 cells.

Recommended Articles
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma
Nov 25, 2025
Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybri……

Aug 07, 2025
Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025
Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.